Results 161 to 162 of about 1,862 (162)
Some of the next articles are maybe not open access.

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes

Journal of Neural Transmission, 2018
Sam Mostafa, Carl Kirkpatrick
exaly  

Solanidine‐derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients

British Journal of Clinical Pharmacology
Julia Stingl   +2 more
exaly  
medicine
pharmacogenomics
neurology
diseases of the nervous system
cyp2c19
pharmacogenetics
cyp2d6
parkinson’s disease
precision medicine
previous   15  16  17  

Home - About - Disclaimer - Privacy